| Name | Title | Contact Details |
|---|
Chesapeake Bank is a community bank located in Kilmarnock, Virginia, serving the Northern Neck and Middle Peninsula regions. Established in April 1900 as Lancaster National Bank, it was founded to support local watermen, oystermen, and fishermen. Over the years, the bank has expanded its services to include farmers and various local businesses, adapting to the needs of the community. The bank offers a variety of banking services, including personal banking options like checking and savings accounts, personal loans, and credit cards. For businesses, Chesapeake Bank provides loans, lines of credit, and cash management services. Additionally, it offers investment services through Chesapeake Wealth Management. Known for its community-focused approach, Chesapeake Bank emphasizes treating customers like neighbors and actively engages in local initiatives.
Kavak is a global company with operations in Mexico, Argentina, Brazil, Chile, Turkey, Saudi Arabia, Oman and United Arab Emirates. We are the number one e-commerce company in the purchase and sale of pre-owned vehicles and the most highly valued private startup in Latin America. Kavak is also the first Unicorn Company in the history of Mexico, with a current valuation of US$8.7 billion. We have thousands of kavak@s from more than 40 different nationalities and growing. As part of this accelerated growth, we want to make sure we surround ourselves with the best talent to help us continue to build the technology, processes and products that will allow us to transform the automotive market around the world. Our team is the number one priority. We like to imagine the impossible and work together to achieve it. We are disruptive, proactive, loyal and ambitious. Interested in joining? Apply now.
First branch of Banka Kombëtare Tregtare was established in Durrës on 29 November 1925, in the historical building where todays BKT Durrës Branch is situated. This building actually represents the oldest Albanian financial institution in the country. Banka Kombëtare Tregtare (BKT), with todays name, was established in January 1993, after the merging of the Albanian Commercial Bank (ACB) and the National Bank of Albania (NBA). The NBA on the other hand was established in 1992 as a result of a second sub-division of the State Bank of Albania. The NBA was set up to manage the domestic trading activity of the State-owned entities. The assets and liabilities from the activities of these two entities were transferred to BKT accounts since it was first established. Banka Kombëtare Tregtare was established as a Joint Stock Company in July 1997, with assets reaching ALL 2.7 billion. In February 2003, with the decision of the Shareholders General Meeting, the paid-up capital reached the amount of US$ 14, 64 million, turning BKT into the most capitalized bank in the whole Albanian banking system. The year 2006 started with a new vision for BKT. With the authorization of the Bank of Albania and pursuant to the specific court decision issued on June 9, 2006, it was approved the transfer of 60% plus 2 of the BKT shares possessed by Kent Bank in favour of Calik-Seker Konsorsiyum Yatirim A.S. On September 3, BKT opened its branch in Kosova and since that time, BKT Kosova has already opened 27 branches, ranking Banka Kombëtare Tregtare as the largest Albanian bank in the region. On June 30, 2009 Çalik Financial Services buys to IFC and EBRD shares being in this way the only BKT shareholder owning 100 % of the shares. On 30th April 2018 Banka Kombëtare Tregtare Kosova Branch, changes its status from Branch of a Foreign Bank to a subsidiary Bank. Now, its banking license has changed from Banka Kombëtare Tregtare Kosova Branch, to Banka Kombëtare Tregtare Kosovë J.S.C.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
The Legal Marketing Association (LMA) is a not-for-profit organization established in 1985, dedicated to supporting professionals in legal marketing, business development, client service, and communications. With over 4,200 members from 49 U.S. states and 28 countries, LMA serves a diverse community that includes in-house marketers, consultants, lawyers, and marketing students. The organization emphasizes ethical standards, thought leadership, and professional advocacy. LMA provides a range of professional development resources, including educational programs, networking opportunities, and publications. Its Body of Knowledge (BoK) framework defines essential skills for legal marketers, while various events and webinars promote knowledge sharing and innovation. LMA fosters a collaborative environment where members can connect, share best practices, and advance their careers in the evolving landscape of legal marketing.